Viewing Study NCT01526512


Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2026-02-26 @ 11:53 PM
Study NCT ID: NCT01526512
Status: UNKNOWN
Last Update Posted: 2012-02-07
First Post: 2012-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast Cancer
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metronomic cyclophosphamide View
None Metronomic capecitabine View
None HER2-negative breast cancer View